Biologicals

Hepatitis

Hepatitis A vaccine

Title: Requirements for hepatitis A vaccines (inactivated); Adopted 1994, TRS No 858, Annex 2

Hepatitis B vaccines, DNA recombinant

Recommendations to Assure the Quality, Safety and Efficacy of Recombinant Hepatitis B Vaccines. Proposed replacement of: TRS 786, Annex 2 and TRS 889, Annex 4.

Hepatitis B vaccine, plasma

Hepatitis WHO Working Group on Hepatitis and HIV Diagnostic Kits

Expert Committee on Biological Standardization, Geneva, 17-21 November 2003

NEW PUBLICATIONS

TRS 1004 - WHO Expert Committee on Biological Standardization, Sixty-seventh report

UPCOMING EVENTS


  • WHO Working Group meeting on Respiratory Syncytial Virus (RSV) Vaccine Standardization, WHO headquarters, Geneva, Switzerland, 13-15 September 2017
  • WHO Second Working Group Meeting on Developing WHO Guidelines on safe production of polio vaccines, WHO HQ Salle D, 19-20 September 2017
  • WHO Workshop on Implementation of Good Manufacturing Practices for Biological Products, Bangkok, Thailand 15-17 November 2017
  • WHO Implementation Workshop on the Quality, Safety and Efficacy of Typhoid Conjugate Vaccines, Osong, Chungju-si, The Republic of Korea, 21-13 November 2017

Contacts


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971